[Form 4] Radian Group Inc. Insider Trading Activity
Radian Group Inc. (RDN) Form 4: Howard Bernard Culang, a director serving as Non-Executive Chairman, reported a transaction dated 09/09/2025 receiving 510.42 shares as dividend equivalent rights on previously awarded phantom stock units. The dividend equivalents were recorded at a price of $0 and will be settled proportionately with the underlying phantom stock awards and converted to stock upon retirement from the Board. Following this reported transaction, Mr. Culang beneficially owns 12,577.556 shares directly. The filing was signed under power of attorney by Elizabeth Diffley on 09/11/2025.
- Director alignment with shareholders: Dividend equivalents are being converted to stock, which ties director compensation to equity performance.
- Transparent disclosure: The Form 4 clearly states transaction date, amount (510.42 shares), and post-transaction direct ownership (12,577.556 shares).
- None.
Insights
TL;DR: Director received dividend equivalent shares from phantom awards; settlement occurs on retirement, indicating typical non-cash compensation alignment.
The Form 4 shows a routine compensation-related issuance: dividend equivalent rights accrued on phantom stock units were recorded and converted to 510.42 shares at a $0 price. The filing explicitly states these dividend equivalents will be settled proportionately with the underlying awards and in stock upon the director's retirement. This mechanism is commonly used to align long-term director incentives with shareholder outcomes without immediate cash outflow. No additional cash consideration or sales are reported, and the report lists direct beneficial ownership after the transaction.
TL;DR: The transaction is an internal compensation accounting event with limited immediate market impact based on disclosed details.
The entry records 510.42 shares credited as dividend equivalents on phantom stock units, with a recorded price of $0 and direct ownership totaling 12,577.556 shares after the transaction. The Form 4 provides transaction date and settlement mechanics but does not indicate any sale, purchase for value, or change in voting control. From a securities perspective, this is a disclosure of issuance related to director compensation rather than a market transaction that would directly alter float or signal active trading by the insider.